Medications/Drugs News Headlines - Yahoo! News
Regeneron, Sanofi win stay of U.S. order blocking cholesterol drug sales
A U.S. appeals court on Wednesday stayed an order that would have blocked Regeneron Pharmaceuticals Inc and Sanofi SA from selling their cholesterol drug, Praluent, while they appeal the order. A federal judge earlier had blocked sales of the drug after rival Amgen Inc won a trial in which it accused them of infringing its patents. Regeneron general counsel Joseph LaRosa said in a statement the company would continue to defend its case through the appeal process.
No comments:
Post a Comment